Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration
2021 ◽
pp. 107098
2011 ◽
Vol 72
(04)
◽
pp. 464-472
◽
2017 ◽
Vol 51
(1)
◽
pp. 111-117
◽
2012 ◽
Vol 73
(06)
◽
pp. 856-864
◽